Engineer and endocrinologist Rayhan Lal, from Stanford University in California, USA, explains the phenomenon of DIY closed-loop insulin delivery and what to do if a patient wants to adopt it.
Lori Berard comments on the results of a study that identifies barriers to basal insulin initiation and factors associated with insulin interruption among patients with type 2 diabetes (2:14).
Hyperglycemia management in type 2 diabetes guidelines author Melanie Davies discusses the key updates in the 2018 edition, the evidence behind them, and the experience of being part of a trans-Atlantic consensus group (5:13).
Professor Miles Fisher talks about the how the UKPDS shook up the treatment landscape for people with diabetes and set the stage for modern clinical research (3:13).
Dana Dabelea discusses the RISE investigators’ findings about the physiology of type 2 diabetes in children and the effects of medication on its progression (7:38).
Medha Munshi comments on the VADT trial, showing that the cardioprotective effect of intensive glycemic control in patients with type 2 diabetes disappears after 15 years (3:04).